Pharmadule Morimatsu
Private Company
Total funding raised: $45M
Overview
Pharmadule Morimatsu is a pioneer and leader in the modular delivery of pharmaceutical manufacturing facilities, founded in Sweden in 1986. As part of the Morimatsu Group, it combines process equipment expertise with modular construction to offer turnkey solutions, boasting over 80 projects delivered worldwide. Its business model focuses on reducing client risk through fixed-price contracts, accelerated timelines, and flexible, expandable designs, primarily serving pharmaceutical and consumer products companies.
Technology Platform
Modular delivery concept for pharmaceutical manufacturing facilities; design and fabrication of prefabricated, cGMP-compliant modules in controlled factory settings for rapid on-site assembly.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes with traditional Engineering, Procurement, and Construction (EPC) firms and other specialized modular facility providers. Differentiation lies in its pioneering history, fixed-price/firm-schedule model, massive manufacturing scale within Morimatsu Group, and integrated offering of facilities with process equipment.